-
admin
Posts
Goldwind Showcases E-SaaS+ Innovations at The smarter E Europe, Marking Expansion into International Energy Storage Market
MUNICH, June 21, 2024 /PRNewswire/ — From June 19th to 21st, Goldwind Carbon Neutral, a wholly-owned subsidiary of Goldwind Science & Technology Co., Ltd., the...
Leslie’s, Inc. Appoints Lorna Nagler to Board of Directors
PHOENIX, June 20, 2024 (GLOBE NEWSWIRE) — Leslie’s, Inc. (“Leslie’s” or the “Company”; NASDAQ: LESL), the largest and most trusted direct-to-consumer brand in the U.S....
Toll Brothers City Living and Sculptor Real Estate Announce Construction is Complete at The Rockwell, its Newest Condominium on Manhattan’s Upper West Side, as First Residents Take Occupancy
Luxury condominiums on 103rd Street & Broadway boast exceptional amenities near Riverside Park NEW YORK, June 20, 2024 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:...
May Retail Sales Reveal Early Signs of Spending Stabilization, Reports Circana
Pockets of growth vary, but promotions are resonating with consumers as their needs change CHICAGO, June 20, 2024 (GLOBE NEWSWIRE) — CHICAGO, June 20, 2024...
PodcastOne’s (Nasdaq: PODC) Gals on the Go and Skincare Leader fresh Team for Live Podcast Event at the Second Annual fresh Beauty Rose Pop-Up in New York
Hosts Danielle Carolan and Brooke Miccio Set to Celebrate fresh’s Rose Collection with Podcast and In Person Meet & Greet LOS ANGELES, June 20, 2024...
Rakovina Therapeutics Announces Oversubscribed Private Placement and Results from 2024 Annual General Meeting
All dollar amounts reflected in Canadian dollars unless otherwise stated VANCOUVER, British Columbia, June 20, 2024 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSXV: RKV) (the...
Cellectis Publishes a Scientific Article Unveiling Three Key Factors for Efficient TALE Base Editing
NEW YORK, June 20, 2024 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing...
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
NOVATO, Calif., June 20, 2024 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies...
NextCure to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
BELTSVILLE, Md., June 20, 2024 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class...
$1.1 million for new brain injury research in Canada
Brain Canada and Brain Changes Initiative (BCI) to support innovative projects that will address some of the most pressing issues in TBI MONTREAL, June 20,...